Alnylam EVP & Chief Legal Officer Indrani Franchini to depart March 1, 2024

ALNYLAM PHARMACEUTICALS, INC.

Indrani L. Franchini to transition from EVP, Chief Legal Officer and Secretary effective March 1, 2024.
Mutual agreement reached on January 12, 2024; severance terms to be formalized in a written agreement on or before the separation date.
No replacement has been named for the Chief Legal Officer and Secretary role.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Indrani L. Franchini

Executive Vice President, Chief Legal Officer and Secretary

ALNY · ALNYLAM PHARMACEUTICALS, INC.

Effective: 2024-03-01
Filed: January 19, 2024, 6:59 PM ET

On January 12, 2024, Alnylam Pharmaceuticals, Inc. (the “Company”) and Indrani L. Franchini agreed that she would transition from her role as the Company’s Executive Vice President, Chief Legal Officer and Secretary, effective as of March 1, 2024

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Indrani L. Franchini changed role as Executive Vice President, Chief Legal Officer and Secretary at ALNYLAM PHARMACEUTICALS, INC..

Action: transition
Role: Executive Vice President, Chief Legal Officer and Secretary

Exact text from the filing

On January 12, 2024, Alnylam Pharmaceuticals, Inc. (the “Company”) and Indrani L. Franchini agreed that she would transition from her role as the Company’s Executive Vice President, Chief Legal Officer and Secretary, effective as of March 1, 2024

View on SEC.gov

ALNYLAM PHARMACEUTICALS, INC. filing history →

Source: SEC EDGAR

accession 0001193125-24-011278

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.